Logo Medical Science Monitor Basic Research

Call: 1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research

02 September 1996

Flumazenil improves oxygenation in patients sedated with benzodiazepines plus opioids

Avi A. Weinbroum, Valery Rudick, Pinhas Halpern, Patrick Sorkine, David Niv, Ron Flaishon, Eran Geller

Med Sci Monit 1996; 2(5): CR539-547 :: ID: 500009

Abstract

Background: It was suggested that hypoxemia, hypercapnea or apnea occur following administration of flumazenil in patients previously sedated with benzodiazepines alone or in combination with opiates. This prospective, randomized study tested this contention and the possible correlation between reversal of sedation and respiratory parameters. Methods: Seventy-eight patients who underwent lower abdominal surgery under general anesthesia (Group GA, n =24) or epidural block (Groups EMD, n =26, and ED=28) comprised the study groups. GA and EMD patients were premedicated with diazepam 10 mg PO and morphine sulphate 0.1 mg.,kg-1, IM; ED patients received only diazepam. IV meperidine (total of 1 mg.,kg-1,) and midazolam (0.1 mg.,kg-1,) were intermittently administered intraoperatively to GA and EMD; ED patients received only midazolam. In the recovery room, while all subjects were breathing room air, flumazenil 1 mg was administered randomly to one half of each groups. Results: Six patients suffered from hypoxemia (SpO2, < 90% for ±15 sec) before study started. No apnea, increase in end-expiratory CO2 (ETCO2) or decrease in pulse oxymetry (SpO2,) were observed during the study. Sedation was reversed promptly, lasting 45 (ED), 3 0 (EMD) and 10 min (GA). Ninety percent of ED-treated patients were vigil (lying with eyes open) twice as long as GA- and EMD-treated patients. SpO2, in GA- and EMD-treated patients did not change after flumazenil; it increased in the ED subgroup where ET,CO2, decreased and respiratory rate increased too. Sedation score significantly (P =0.0000) correlated with SpO2, in ED- and EMD-treated patients (rp,=-0.92, -0.96, respectively) and with ET,C02, in GA-treated patients only (P<0.05, rp,=-0.88). Heart rate and blood pressure did not change following flumazenil administration. Conclusions: Flumazenil does not cause deterioration in respiratory parameters after benzodiazepines alone or when combined with meperidine, but rather ameliorates them. Significant close correlation between reversal of sedation and SpO2, exists under epidural and general anesthesia.

Keywords: Benzodiazepines, opiates, Flumazenil, sedation, pulse oxymetry, end-expiratory carbon dioxide

0 Comments

Most Viewed Current Articles

13 Apr 2020 : Original article  

Outcome of 24 Weeks of Combined Schroth and Pilates Exercises on Cobb Angle, Angle of Trunk Rotation, Chest...

DOI :10.12659/MSMBR.920449

Med Sci Monit Basic Res 2020; 26:e920449

11 May 2020 : Original article  

Analysis of Psychological and Sleep Status and Exercise Rehabilitation of Front-Line Clinical Staff in the ...

DOI :10.12659/MSMBR.924085

Med Sci Monit Basic Res 2020; 26:e924085

05 Jan 2021 : Review article  

A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against...

DOI :10.12659/MSMBR.929207

Med Sci Monit Basic Res 2021; 27:e929207

10 Aug 2020 : Clinical Research  

Effects of Cognitive Task Training on Dynamic Balance and Gait of Patients with Stroke: A Preliminary Rando...

DOI :10.12659/MSMBR.925264

Med Sci Monit Basic Res 2020; 26:e925264

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor Basic Research eISSN: 2325-4416
Medical Science Monitor Basic Research eISSN: 2325-4416